DrugPatentWatch Database Preview
Bionpharma Inc Company Profile
What is the competitive landscape for BIONPHARMA INC, and what generic alternatives to BIONPHARMA INC drugs are available?
BIONPHARMA INC has twenty-eight approved drugs.
There are four US patents protecting BIONPHARMA INC drugs.
There are ten patent family members on BIONPHARMA INC drugs in thirteen countries and twenty-nine supplementary protection certificates in eleven countries.
Summary for Bionpharma Inc
| International Patents: | 10 |
| US Patents: | 4 |
| Tradenames: | 26 |
| Ingredients: | 23 |
| NDAs: | 28 |
| Drug Master File Entries: | 2 |
| Patent Litigation for Bionpharma Inc: | See patent lawsuits for Bionpharma Inc |
Drugs and US Patents for Bionpharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bionpharma Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET;ORAL | 209753-003 | Mar 2, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Bionpharma Inc | IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride; ibuprofen | CAPSULE;ORAL | 090397-001 | Nov 22, 2010 | OTC | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Bionpharma Inc | LOPERAMIDE HYDROCHLORIDE | loperamide hydrochloride | CAPSULE;ORAL | 021855-002 | Aug 4, 2005 | OTC | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Bionpharma Inc | CALCITRIOL | calcitriol | CAPSULE;ORAL | 091174-001 | May 24, 2013 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Bionpharma Inc | AZITHROMYCIN | azithromycin | TABLET;ORAL | 209999-001 | Dec 26, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Bionpharma Inc | BENZONATATE | benzonatate | CAPSULE;ORAL | 081297-002 | Oct 30, 2007 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Bionpharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bionpharma Inc | MIDOL LIQUID GELS | ibuprofen | CAPSULE;ORAL | 021472-001 | Oct 18, 2002 | 6,251,426 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for Bionpharma Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Denmark | 1863458 | ➤ Sign Up |
| European Patent Office | 3061447 | ➤ Sign Up |
| Lithuania | 1863458 | ➤ Sign Up |
| Portugal | 1863458 | ➤ Sign Up |
| Cyprus | 1118321 | ➤ Sign Up |
| Hungary | E030784 | ➤ Sign Up |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for Bionpharma Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0387077 | SPC/GB04/003 | United Kingdom | ➤ Sign Up | PRODUCT NAME: PARICALCITOL; REGISTERED: ES SPAIN 64.974 20020809; UK PL 00037/0403 20030721 |
| 0663828 | C300085 | Netherlands | ➤ Sign Up | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
| 0637297 | SPC/GB01/041 | United Kingdom | ➤ Sign Up | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB01/041 GRANTED TO EISAI R + D MANAGEMENT., LTD. IN RESPECT OF THE PRODUCT BEXAROTENE (4-(1-(3, 5, 5, 8, 8-PENTAMETHYL-5, 6, 7, 8-TETRAHYDRO-2-NAPHTHALENYL)VINYL)BENZOIC ACID), WHICH WAS ADVERTISED AS COMING INTO FORCE IN JOURNAL NO 6469 DATED 15/05/2013 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, IT WILL EXPIRE ON 01/04/2016. |
| 0637297 | 01C0027 | France | ➤ Sign Up | PRODUCT NAME: BEXAROTENE; REGISTRATION NO/DATE: EU/1/01/178/001 20010329 |
| 0152897 | SPC/GB01/012 | United Kingdom | ➤ Sign Up | PRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115 |
| 1411900 | 1190013-1 | Sweden | ➤ Sign Up | PRODUCT NAME: NAPROXEN OCH ESOMEPRAZOL; NAT. REG. NO/DATE: MTNR 43248 20101203; FIRST REG.: GB PL 17901/0263 20101105 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
